Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Stop the silent misdiagnosis: patients' preferences matter.
Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model.
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.
[Analysis of clinical pathway in changing and disabling neurological diseases.]
Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders.
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.
Teriflunomide for the treatment of multiple sclerosis.
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
IFN-β differentially regulates the function of T cell subsets in MS and EAE.
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS.
Spanish consensus on the use of natalizumab (Tysabri(®))-2013.
Endogenous Two-Photon Excited Fluorescence Provides Label-Free Visualization of the Inflammatory Response in the Rodent Spinal Cord.
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention.
Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study.
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.
Preference-based Health status in a German outpatient cohort with multiple sclerosis.
Pages
« first
‹ previous
…
510
511
512
513
514
515
516
517
518
…
next ›
last »